SLOW AND STEADY: European biotech company Galapagos's U.S.-listed shares surged 17.6% after Gilead Sciences invested $5 billion in it.
News
- US stocks drift sideways as curtain rises for earning season
- Celcuity Inc. (CELC) EPS Estimated At $-0.20
... Studies at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with ... Bizjournals.com and their article: “Biotech startup Celcuity raises $23M in IPO – Minneapolis / St. Paul Business ...
- Pet Talk: The benefits of a balanced microbiome
Dr. Audrey Cook, an associate professor at the Texas A&M College of Veterinary Medicine & Biomedical Sciences, discusses the importance of a ...
- Buyer of RK Group Property Planning Major East Side Development
The proposed redevelopment would mark a significant investment in San Antonio's near East Side, which has seen residential redevelopment in ...
- In memoriam: UTSA founding faculty and professor emeritus Paul H. Rodríguez dies at age 81
He served as program director for the Minority Biomedical Research ... student attending a SACNAS conference in San Antonio in the late 80s.